{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for estramustine root_relationships_relatedSubstance_refPname in Related Substance Name (approximate match)
Status:
Withdrawn
Source:
Clomacran [UK]
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
CLOMACRAN, a non-phenothiazine tricyclic compound, is an antipsychotic drug.
Status:
Possibly Marketed Outside US
Source:
NCT04026438: Phase 4 Interventional Completed Complication, Postoperative
(2019)
Source URL:
First approved in 1983
Source:
NADA125961
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(2017)
Source:
BLA761047
(2017)
Source URL:
First approved in 2017
Source:
BLA761047
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2015)
Source:
BLA125513
(2015)
Source URL:
First approved in 2015
Source:
BLA125513
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03319628: Phase 1/Phase 2 Interventional Active, not recruiting Platinum Resistant Ovarian Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:LIFASTUZUMAB [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01995188: Phase 1 Interventional Completed Non-Squamous Non-Small Cell Lung Cancer
(2013)
Source URL:
Class:
PROTEIN
